WHO ICTRP trial
FORWARD: EMDR for fear of cancer recurrence
NL-OMON50927 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON50927 |
|---|---|
| Public title | FORWARD: EMDR for fear of cancer recurrence |
| Scientific title | FORWARD: EMDR for fear of cancer recurrence - FORWARD |
| Primary sponsor | Universiteit van Tilburg |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | fear of cancer recurrence; anxiety about cancer coming back;10002861;fear of cancer recurrence; anxiety about cancer coming back |
| Interventions | The Dutch EMDR-protocol will be used, in which the flash forward is an important feature. The *flash forward* focuses on catastrophic scenarios in the future. This protocol contains two to five weekly sessions. ;eye movement desensitization… |
| Registration date | Feb 25, 2021 |
| Target size | 7 |
| Secondary IDs | NL76078.028.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: